@article{b82df7febf924ce38b3e942c38d5f2d5,
title = "The effect of an end-of-clerkship review session on NBME psychiatry subject exam scores",
abstract = "Objective: The NBME Psychiatry Subject Examination (PSE) is used throughout North America to test MS-III end-of-clerkship knowledge; yet, literature on PSE preparatory methods remains sparse. This study assesses the effect of a curriculum intervention on NBME PSE scores. Method: An optional 1.5-hour review session and accompanying fill-in-the-blank handout was offered to 62 MS-III students 3 days before their exam. Students who did not attend the session were e-mailed the handout with completed answers. The primary outcome measure was a change in scores, with students in the previous year serving as the control group. Results: The average raw PSE score of students offered the review session was 84.53, versus 77.15 for matched controls (p ,0.0001). The effect size for the intervention was 0.89. Conclusion: This study may suggest that offering a comprehensive review session to third-year medical students 3 days before their NBME PSE significantly improves their scores.",
author = "Sidhu, {Shawn S.} and Chandra, {Rohit M.} and Lei Wang and Gollan, {Jacqueline K.} and Sonya Rasminsky and Brar, {Simerjeet K.} and Anzia, {Joan M.}",
note = "Funding Information: In conclusion, despite its limitations, this study supports the use of a review session and accompanying handout as a form of curriculum intervention aimed at improving PSE scores. These results will need to be replicated at other institutions for improved reliability, and a more sophisticated understanding of the interaction between shelf reviews and PSE scores is needed.Dr. Gollan has received research support from National Institute of Mental Health, National Alliance for Research in Schizophrenia and Depression, and the American Foundation of Suicide Prevention. She has received royalties from the American Psychological Association and Guilford Press. She has owned shares of Pfizer and Bristol-MyersSquibb stock and has received speaker honoria from AstraZeneca. She is a consultant for Prevail, Inc. All other authors had no involvements that might raise questions of bias in their role as authors for Academic Psychiatry.",
year = "2012",
month = may,
doi = "10.1176/appi.ap.10120166",
language = "English (US)",
volume = "36",
pages = "226--228",
journal = "Academic Psychiatry",
issn = "1042-9670",
publisher = "American Psychiatric Publishing Inc.",
number = "3",
}
